Table 1.

Baseline characteristics of participants.

	HG	LG
Number	14	22
Age (years)	56 ± 14	65 ± 11*
Female (n)	4	8
Side of paresis	6 R, 8 L	13 R, 9 L
Type of stroke	12 I, 2 H	20 I, 2 H
Time since stroke at program initiation (days)	49 ± 17	49 ± 17
FMA score (/66 points)	29 ± 13	34 ± 12

Results are expressed as mean ± SD.

HG, higher dose group; LG, lower dose group; R, right; L, left; I, ischemia; H, hemorrhage; FMA, Fugl-Meyer Assessment.

^*p < 0.05, T-test, HG vs. LG.